Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and radiographic disease progression as well as on pa...

Full description

Bibliographic Details
Main Authors:	Valeria Nucera, Elisabetta Gerratana, Manuela Giallanza, Laura La Corte, Donatella Sangari
Format:	Article
Language:	English
Published:	BioExcel Publishing Ltd 2021-01-01
Series:	Drugs in Context
Subjects:	comorbidities connective tissue diseases cyclophosphamide disease-modifying antirheumatic drugs interstitial lung diseases
Online Access:	https://www.drugsincontext.com/efficacy-of-cyclophosphamide-in-treating-connective-tissue-disease-related-interstitial-lung-diseases

Similar Items

Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue
by: Gian Luca Erre, et al.
Published: (2021-01-01)

Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis
by: D V Bestaev, et al.
Published: (2013-05-01)

Cyclophosphamide for interstitial lung disease-associated acute respiratory failure: mortality, clinical response and radiological characteristics
by: Johanna P. van Gemert, et al.
Published: (2021-07-01)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
by: Hongseok Yoo, et al.
Published: (2021-01-01)

Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management
by: Chung, M.P, et al.
Published: (2022)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
by: Mehdi Mirsaeidi, et al.
Published: (2019-10-01)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
by: Adelle S. Jee, et al.
Published: (2017-05-01)

Exacerbation of connective tissue disease-associated interstitial lung disease due to influenza vaccination
by: Tai Okusaki, et al.
Published: (2021-01-01)

Selection of glucocorticoid-sensitive patients in interstitial lung disease secondary to connective tissue diseases population by radiomics
by: Feng DY, et al.
Published: (2018-10-01)

Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease
by: Magdalena Celińska-Löwenhoff, et al.
Published: (2019-01-01)

Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease
by: Bao Y, et al.
Published: (2021-06-01)

The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease
by: Hua Ma, et al.
Published: (2020-01-01)

Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01)

Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment – a German claims data analysis
by: Julia Wälscher, et al.
Published: (2020-03-01)

Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study
by: Chrystal Chan, et al.
Published: (2019-10-01)

Comparison of clinical courses and mortality of connective tissue disease‐associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias
by: Fatma Yıldırım, et al.
Published: (2019-06-01)

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
by: Belén Atienza-Mateo, et al.
Published: (2020-05-01)

Antifibrotics in interstitial lung disease related to connective tissue diseases - a paradigm shift in treatment and outcome
by: Ana Catarina Duarte, et al.
Published: (2019-04-01)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021-01-01)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
by: Gian Luca Erre, et al.
Published: (2021-01-01)

The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease
by: Alberto Ricci, et al.
Published: (2021-04-01)

A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis
by: Hai Qin Xie, et al.
Published: (2019-04-01)

Disease-modifying antirheumatic drugs – Old and new: A brief overview
by: Vidya Divakar Baliga, et al.
Published: (2019-01-01)

Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view?
by: Alice Biffi, et al.
Published: (2018-09-01)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01)

A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
by: Alyson W. Wong, et al.
Published: (2020-12-01)

Lung Cancer development and mortality in interstitial lung disease with and without connective tissue diseases: a five-year Nationwide population-based study
by: Won-Il Choi, et al.
Published: (2019-06-01)

Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
by: Jeong Seok Lee, et al.
Published: (2019-02-01)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
by: So-My Koo, M.D., et al.
Published: (2019-10-01)

Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
by: Mengshu Cao, et al.
Published: (2019-11-01)

Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
by: A. Sclafani, et al.
Published: (2019-11-01)

Picking interstitial lung disease out of the myositis haystack
by: Jennifer Hannah, et al.
Published: (2020-01-01)

Newer insights into the management of interstitial lung disease in systemic sclerosis
by: Robert L Mango, et al.
Published: (2017-01-01)

Lipid profiles in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs
by: Anna Filipowicz-Sosnowska, et al.
Published: (2014-06-01)

Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
by: Caterina Vacchi, et al.
Published: (2020-02-01)

Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations
by: Tihong Shao, et al.
Published: (2021-06-01)

Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
by: Sudip Das, et al.
Published: (2011-01-01)

Clinico-radiological profile of connective tissue disease related-interstitial lung diseases from a tertiary care centre of India: a cross sectional study
by: Mehul Agarwal, et al.
Published: (2021-04-01)

Pathological interpretation of connective tissue disease-associated lung diseases
by: Kun Young Kwon
Published: (2019-01-01)

Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study
by: Claudio Tirelli, et al.
Published: (2020-02-01)